Want to join the conversation?
Pharma company $ALXN said its 3Q15 GAAP net loss was $0.81 per share, compared to diluted GAAP EPS of $0.88 in the third quarter of 2014. This was impacted by $315.6MM or $1.39 per share related to a non-cash deferred income tax expense resulting from the integration of Synageva.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.